ngµç×ÓÓÎÏ·

03
½Ìѧ¿ÆÑÐ
  • 16 2025-07

    ҦЧ¹û¿ÎÌâ×éÌá³ösplicingÒÖÖÆ¹ýÔçmRNA3¡¯×îºó¼Ó¹¤Óëת¼ÖÕÖ¹µÄÆÕÊÊÐÔÀíÂÛ

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÕÅÓñçù£©5¸öpre-mRNA¼ô½Ó½¹µãsnRNP¸´ºÏÌ壨U1, U2, U4, U5, U6£©µÄ¾­µä·Ö×ÓÉúÎïѧ¹¦Ð§ÊÇÉú»¯½Ì¿ÆÊéÖÐÐÎòµÄÕæºËÉúÎïpre-mRNA splicing¹¦Ð§¡£¡£¡£7ÔÂ11ÈÕ£¬ £¬ÖÐɽҽѧԺ¸Éϸ°ûÖÐÐÄҦЧ¹û¿ÎÌâ×éÓ¦ÑûÔÚÒÅ´«Ñ§ÁìÓò¶¥¼¶×ÛÊöÆÚ¿¯¡¶ÒÅ´«Ñ§Ç÷ÊÆ¡·£¨Trends in Genetics£©½ÒÏþÂÛÎÄ£¬ £¬ÖÜÈ«×ܽáÁ˽üÆÚ¹ØÓÚU1/U2/U4/U6 snRNPй¦Ð§µÄÑо¿Ï£Íû£¬ £¬Í¬Ê±ÐðÊöÁËsplicing inhibits PCPA (premature cleavage and polyadenylation) and ...

  • 16 2025-07

    Ò¢½­Ã÷¿ÎÌâ×éÌá³öÈ«ÐÂÒªÁìÔ¼ÊøÎÞÖÐ΢×ÓË«±´ËþË¥±äºË¾ØÕóÔª

    ngµç×ÓÓÎÏ·ÐÂÎÅѶ(ͨѶԱ³Âԣϼ£©¿ËÈÕ£¬ £¬ÎïÀíÓëÌìÎÄѧԺҢ½­Ã÷½ÌÊÚ¿ÎÌâ×éÓëÅ·ÖÞºË×ÓÑо¿ÖÐÐÄ£¨CERN£©Giuliano Giacalone²©Ê¿ÏàÖú£¬ £¬ÔÚÎÞÖÐ΢×ÓË«±´ËþË¥±ä£¨0¦Í¦Â¦Â£©Ñо¿ÖÐÈ¡µÃÐÂÏ£Íû¡£¡£¡£ÍŶÓÌá³öͨ¹ý¸ßÄܺËÅöײʵÑéÖÐÇ¿×Ó¶¯Á¿Ïà¹ØÐÔ£¬ £¬¼ä½ÓÔ¼ÊøºòÑ¡ºËµÄºË¾ØÕóÔª£¨NME£©£¬ £¬Îª½µµÍÆä²»È·¶¨ÐÔÌṩÐÂ˼Ð÷¡£¡£¡£¸ÃЧ¹ûÓÚ7ÔÂ8ÈÕ½ÒÏþÔÚ¡¶ÎïÀí̸Âۿ챨¡·£¨ Physical Review Letters ÉÏ£©¡£¡£¡£2023¼¶Ë¶Ê¿Ñо¿ÉúÀîÒåΪµÚÒ»×÷Õߣ¬ £¬Ò¢½­Ã÷½ÌÊÚºÍGiuliano Giacal...

  • 16 2025-07

    ÀµÓ±Ë¹ÍŶÓÕ¹ÏÖÓ×¶ùÔ°½á¹¹µÐÊÖ×ã¿Ú²¡Èö²¥¶¯Á¦Ñ§¼°·ÇÒ©Îï¸ÉԤЧ¹ûµÄÓ°Ïì

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÀµÓ±Ë¹£©7ÔÂ1ÈÕ£¬ £¬ngµç×ÓÓÎÏ·¹«¹²ÎÀÉúѧԺÀµÓ±Ë¹½ÌÊÚÑо¿ÍŶӹ¹½¨ÁËÒ»¸ö»ùÓÚÄêËê·Ö²ãµÄÖÇÄÜÌåÄ£×Ó£¬ £¬Ä£Ä⺭¸ÇÓ×¶ùÔ°¶ùͯ¡¢Î÷ϯ¡¢ÊÂÇéÖ°Ô±¼°Æä¼ÒÍ¥³ÉÔ±µÄÈËȺ£¬ £¬Á¬ÏµÈö²¥¶¯Á¦Ñ§ºÍ±´Ò¶Ë¹ÒªÁ죬 £¬ÏµÍ³Ä£ÄâÊÖ×ã¿Ú²¡ÔÚÓ×¶ùÔ°Äڵı©·¢Àú³Ì£¬ £¬²¢ÆÀ¹ÀÁËÈýÀà·ÇÒ©Îï¸ÉÔ¤²½·¥£¨¸öÌå¸ôÀ룬 £¬°à¼¶¼°¼ÒÍ¥¸ôÀ룬 £¬Ó×¶ùÔ°Í £¿£¿£¿Î£©¼°ÒßÃç½ÓÖÖ£¨ÏÖÔÚ½öÓÐÕë¶ÔEV-A71¶¾ÖêÒßÃçÉÏÊУ©µÐÊÖ×ã¿Ú²¡µÄ·À¿ØÐ§¹û¡£¡£¡£Ïà¹ØÑо¿½ÒÏþÔÚ¹ú¼Ê×ÅÃûÆÚ¿¯¡¶BMC Ò½...

  • 11 2025-07

    ¹ù½£Æ½ÍŶÓÕ¹ÏÖ¸ßÂѰ×ÒûʳЭÖú»¯ÁÆÖÎÁÆÖ×ÁöµÄлúÖÆ

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±¿µ¾þÃù£©°±»ùËá¡¢ÆÏÌÑÌǺÍÖ¬·¾ËáÊÇÈËÀà´ÓÒûʳÖлñÈ¡µÄÖ÷ÒªÓªÑøÈªÔ´£¬ £¬Ö»¹ÜÁÙ´²ÍƼö°©Ö¢»¼Õß½ÓÄɸßÂѰ×Òûʳ£¬ £¬µ«ÆäÒÖÖÆÖ×ÁöÉú³¤¼°ÔöÇ¿»¯ÁÆÃô¸ÐÐÔµÄ׼ȷ»úÖÆÉÐδÃ÷È·¡£¡£¡£½üÆÚ£¬ £¬Á¥ÊôµÚÒ»Ò½Ôº¹ù½£Æ½Ñо¿Ô±ÍŶӷ¢Ã÷mTORC1-S6K1/TRAF5-AKTÖáÔڽ鵼ÉÅʳÂѰ×Öʵ÷¿Ø°©Ï¸°ûÐÐΪµÄÓ°ÏìÖÐÆðÒªº¦×÷Óᣡ£¡£Ïà¹ØÑо¿½ÒÏþÔÚ¹ú¼Ê×ÅÃûÆÚ¿¯¡¶³¦µÀ¡·£¨GUT£©ÉÏ¡£¡£¡£ÍŶÓͨÏ꾡°ûºÍÌåÍâÁ×Ëữ¼°·ºËØ»¯ÊµÑ飬 £¬·¢Ã÷¸ßÂѰ×ÒûʳÖеݱ»ùËáͨ¹ý¼¤...

  • 11 2025-07

    ÄÉÃס°Ë«¹â×Ó¹¤³§¡±ÎÊÊÀ£¡ngµç×ÓÓÎÏ·¿ÆÑÐÍŶÓÑÐÖÆÐÂÐÍÁ¿×Ó¾À²ø¹âÔ´µÇ¡¶×ÔÈ»¡·

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶(¼ÇÕßÖì¼ÎºÀ Àƽ£©7ÔÂ9ÈÕ£¬ £¬¡¶×ÔÈ»¡·ÔÓÖ¾£¨Nature£©ÔÚÏß½ÒÏþngµç×ÓÓÎÏ·ÎïÀíѧԺÍõÑ©»ª¡¢Áõ½ø½ÌÊÚÍŶÓÖ÷µ¼µÄ×îÐÂÑо¿Ð§¹û¡£¡£¡£ÍŶÓÌá³öÁËÒ»ÖÖȫеÄÇ»ÓÕµ¼×Ô¾õË«¹â×Ó·øÉä·½°¸£¬ £¬ÔÚ¹ú¼ÊÉÏÂÊÏÈʵÏÖÓëµ¥¹â×Ó·øÉäÇ¿¶ÈÏ൱µÄ×Ô¾õË«¹â×Ó·øÉ䣬 £¬Ñз¢³ö±£Õæ¶È¸ß´ï99.4%µÄ°´Ðè´¥·¢Ê½ÐÂÐÍ΢ÄÉÁ¿×Ó¾À²ø¹âÔ´¡£¡£¡£ÕâһЧ¹ûΪÐÂÒ»´úÁ¿×ÓϸÃÜÕÉÁ¿ÊÖÒյĿªÕ¹£¬ £¬ÒÔ¼°¹¦Ð§»¯¹âÁ¿×ÓÐÅÏ¢´¦ÀíоƬµÄ¹¹½¨ÌṩÁËÒªº¦Ö§³Ö¡£¡£¡£ÔÚÁ¿×ÓÌìÏÂÀ £¬Ò»¶Ô¹â×ÓÄÜÏñ...

  • 09 2025-07

    ÑÕ¹âÃÀÁº½ £¿£¿£¿ªÍŶӹ¹½¨¡°Ç¿Ð§ÐÍ¡±ÈÜÁö²¡¶¾M1-mutIL-18

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶ £¨Í¨Ñ¶Ô±Áº½ £¿£¿£¿ª£©ÃâÒßÖÎÁÆÕýÔÚÉî¿Ì²¢ÇÒ¸ùÌìÐԵظÄд¶ñÐÔÖ×ÁöÖÎÁƵÄÀúÊ·¡£¡£¡£¿ÉÊÇ£¬ £¬ÁÙ´²Êý¾ÝÏÔʾ½ö20~40%»¼Õß¶ÔPD1¿¹ÌåÖÎÁÆÓз´Ó³£¬ £¬¶øÕæÕýÄÜʵÏÖÖ×ÁöÍêÈ«»º½âµÄÖ×Áö²¡ÈËÔ¼Õ¼5%¡£¡£¡£Òò´Ë£¬ £¬½¨ÉèÒ»ÖÖ¸ßЧ¡¢×÷Óó¤ÆÚµÄÐÂÐÍ¿¹Ö×ÁöÃâÒßÖÎÁÆÒªÁìÈÔÈ»ÊÇÏÖÔÚ¿¹Ö×ÁöÖÎÁÆÁìÓòÖÐØ½Ðè½â¾öµÄÖ÷Òª¿ÆÑ§ÎÊÌâ¡£¡£¡£7ÔÂ3ÈÕ£¬ £¬ÖÐɽҽѧԺÑÕ¹âÃÀ½ÌÊÚÁº½ £¿£¿£¿ª¸±½ÌÊÚÍŶÓÑо¿·¢Ã÷ÈÜÁö²¡¶¾M1ѬȾ¿ÉÏÔÖøÌáÉýÖ×Áö΢ÇéÐÎÖÐIL-18ÊÜÌåµÄ±í´ï£¬ £¬µ«ÅäÌåIL-18...

  • 09 2025-07

    Íõ½ð¿­¿ÎÌâ×éÕ¹ÏÖm6A½éµ¼ÐÂÐÍ RNAÖÊÁ¿¿ØÖÆ»úÀí

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶(ͨѶԱÍõ½ð¿­£©7ÔÂ1ÈÕ£¬ £¬ÖÐɽҽѧԺÍõ½ð¿­½ÌÊÚ¿ÎÌâ×éÓëÃÀ¹úµÄ·Ñ³Ç¶ùͯҽԺÏàÖúÔÚ¡¶×ÔÈ»¡ª¡ªÍ¨Ñ¶¡·£¨¡¶Nature Communications¡·£©ÉϽÒÏþÑо¿ÂÛÎÄ¡£¡£¡£¸ÃÂÛÎÄ¿ª·¢ÁËm6A-isoSC-seqÊÖÒÕ£¬ £¬Ê¹Óõ¥Ï¸°ûÅ£½òÄÉÃ׿׳¤¶Á³¤²âÐò£¬ £¬Í¨¹ýAPOBEC1-YTHÓÕµ¼µÄC-to-UÍ»±äÂÊÀ´ÕÉÁ¿m6AµÄÐÞÊÎˮƽ£¬ £¬Ê×´ÎʵÏÖÁ˵¥Ï¸°û·Ö±æÂÊÏÂÈ«³¤×ªÂ¼±¾µÄm6AÐÞÊÎͼÆ×»æÖÆ¡£¡£¡£Ô½À´Ô½¶àµÄÑо¿Åú×¢£¬ £¬RNAµÄ¼Ó¹¤Àú³Ìµ÷¿Øm6AµÄÐγÉ£¬ £¬ÍâÏÔ×ÓÌÖÂÛ¸´ºÏÎEJC£©»áÒÖ...

  • 02 2025-07

    ÕÅÁ¦¡¢·½ÎÄ·åÍŶÓÐÂÑо¿ÆÆ½â·Î°©ÄÍÒ©À§¾Ö

    ¿ËÈÕ£¬ £¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐĽÌÊÚÕÅÁ¦¡¢·½ÎÄ·åÍŶÓÔÚ¡¶Ó¢¹úҽѧÔÓÖ¾¡·½ÒÏþÁËÈ«ÇòÊ׸ö»ñÅúÓÃÓڷΰ©µÄTROP2¿¹ÌåżÁªÒ©ÎADC£©Â«¿µÉ³Í×Öéµ¥¿¹Ôڷΰ©ÁìÓòµÄÍ»ÆÆÐÔÑо¿Ð§¹û¡£¡£¡£·Î°©ÊÇÏÖÔÚÈ«Çò·¢²¡ÂʺÍéæÃüÂʾùÅÅÃûµÚÒ»µÄ°©Ö¢£¬ £¬ÆäÖзÇСϸ°û·Î°©£¨NSCLC£©Õ¼·Î°©²¡ÀýµÄ80%~85%¡£¡£¡£¹ØÓÚ±íÆ¤Éú³¤Òò×ÓÊÜÌ壨EGFR£©Í»±äµÄÍíÆÚNSCLC»¼Õߣ¬ £¬Ö»¹Ü°ÐÏòEGFRÍ»±äµÄÀÒ°±ËἤøÒÖÖÆ¼Á£¨EGFR-TKI£©´øÀ´ÁËÏÔÖøµÄ³õʼÁÆÐ§£¬ £¬µ«´ó´ó¶¼»¼Õß×îÖÕ¶¼»á±¬·¢ÄÍÒ©ÐÔ...

¡¾ÍøÕ¾µØÍ¼¡¿